187 related articles for article (PubMed ID: 37547717)
41. FARP1 Facilitates Cell Proliferation Through Modulating MAPK Signaling Pathway in Cutaneous Melanoma.
Chen ZH; Wang LH
Am J Dermatopathol; 2019 Dec; 41(12):908-913. PubMed ID: 31021836
[TBL] [Abstract][Full Text] [Related]
42. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
Qiao Y; Wang B; Yan Y; Niu L
Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
[TBL] [Abstract][Full Text] [Related]
43. Knockdown of PLCB2 expression reduces melanoma cell viability and promotes melanoma cell apoptosis by altering Ras/Raf/MAPK signals.
Zhang H; Xie T; Shui Y; Qi Y
Mol Med Rep; 2020 Jan; 21(1):420-428. PubMed ID: 31746389
[TBL] [Abstract][Full Text] [Related]
44. Long Non-Coding RNA LINC01260 Inhibits the Proliferation, Migration and Invasion of Spinal Cord Glioma Cells by Targeting CARD11 Via the NF-κB Signaling Pathway.
Wu DM; Han XR; Wen X; Wang S; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Zheng YL
Cell Physiol Biochem; 2018; 48(4):1563-1578. PubMed ID: 30071522
[TBL] [Abstract][Full Text] [Related]
45. Upregulation of DJ-1 expression in melanoma regulates PTEN/AKT pathway for cell survival and migration.
Lee YJ; Kim WI; Park TH; Bae JH; Nam HS; Cho SW; Choi YJ; Lee SH; Cho MK
Arch Dermatol Res; 2021 Sep; 313(7):583-591. PubMed ID: 32959108
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma.
Zhao CC; Guo H; Wang Y; Li JH
Hum Cell; 2021 Mar; 34(2):654-666. PubMed ID: 33400243
[TBL] [Abstract][Full Text] [Related]
47. SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma.
Hou Y; Wang Z; Huang S; Sun C; Zhao J; Shi J; Li Z; Wang Z; He X; Tam NL; Wu L
Cell Death Dis; 2019 Dec; 10(12):929. PubMed ID: 31804459
[TBL] [Abstract][Full Text] [Related]
48. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
49. Synergistic Antitumor Effect of BKM120 with Prima-1Met Via Inhibiting PI3K/AKT/mTOR and CPSF4/hTERT Signaling and Reactivating Mutant P53.
Li Z; Xu X; Li Y; Zou K; Zhang Z; Xu X; Liao Y; Zhao X; Jiang W; Yu W; Guo W; Chen Y; Li Y; Chen M; Deng WG; Li L; Zou L
Cell Physiol Biochem; 2018; 45(5):1772-1786. PubMed ID: 29495002
[TBL] [Abstract][Full Text] [Related]
50. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
51. Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53-dependent signaling pathway.
Li M; Yang X; Zhang G; Wang L; Zhu Z; Zhang W; Huang H; Gao R
Thorac Cancer; 2022 May; 13(9):1311-1321. PubMed ID: 35352475
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic effects of β-elemene via attenuation of the Wnt/β-catenin signaling pathway in cervical cancer cells.
Wang L; Zhao Y; Wu Q; Guan Y; Wu X
Mol Med Rep; 2018 Mar; 17(3):4299-4306. PubMed ID: 29363722
[TBL] [Abstract][Full Text] [Related]
53. RECK inhibits cervical cancer cell migration and invasion by promoting p53 signaling pathway.
Liu Y; Li L; Liu Y; Geng P; Li G; Yang Y; Song H
J Cell Biochem; 2018 Apr; 119(4):3058-3066. PubMed ID: 29064588
[TBL] [Abstract][Full Text] [Related]
54. RBM4 inhibits the growth of clear cell renal cell carcinoma by enhancing the stability of p53 mRNA.
Jian W; Xue W; Wang T; Yu Y; Cai L; Meng Y; Xia Z; Zhang C
Mol Carcinog; 2023 Apr; 62(4):464-478. PubMed ID: 36585906
[TBL] [Abstract][Full Text] [Related]
55. Dual VEGF/PDGF knockdown suppresses vasculogenic mimicry formation in choroidal melanoma cells via the Wnt5a/β-catenin/AKT signaling pathway.
Yuan Y; Geng B; Xu X; Zhao H; Bai J; Dou Z; Jia S; Yu X; Luo W
Acta Histochem; 2022 Jan; 124(1):151842. PubMed ID: 34995928
[TBL] [Abstract][Full Text] [Related]
56. Abnormal Expression of Centromere Protein U Is Associated with Hepatocellular Cancer Progression.
Yu Y; Chen X; Zhang W; Liu J
Biomed Res Int; 2021; 2021():4051192. PubMed ID: 34957303
[TBL] [Abstract][Full Text] [Related]
57. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
[TBL] [Abstract][Full Text] [Related]
58. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
Chen X; Gao J; Yu Y; Zhao Z; Pan Y
Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
[TBL] [Abstract][Full Text] [Related]
59. miR-302a-3p suppresses melanoma cell progression via targeting METTL3.
Chang X; Lin YY; Bai LN; Zhu W
J Chemother; 2022 Feb; 34(1):55-66. PubMed ID: 34286671
[TBL] [Abstract][Full Text] [Related]
60. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]